Skip to main content

FDA recall, , Moderate risk

Fresenius Kabi Ivenix Infusion System LVP Software

The Ivenix Infusion System LVP Software has instructions for LVP duration programming that are emphasized in the IFU.

What happened

Fresenius Kabi USA, LLC of North Andover, Massachusetts is recalling 30 units of the Ivenix Infusion System (IIS) LVP Software: LVP-SW-0005. The agency stated the reason is emphasizing instructions for LVP duration programming located in the IFU. The company began the recall on November 21, 2025, and it was added to the FDA's Enforcement Report on January 12, 2026.

Distribution was nationwide in states including California, Colorado, Florida, Georgia, Idaho, Illinois, Maryland, Michigan, Minnesota, Mississippi, Nebraska, New Jersey, Nevada, Oklahoma, Oregon, South Carolina, Texas, Virginia, Washington and Wisconsin.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Affected if its UDI-DI matches.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Ivenix Infusion System (IIS), LVP Software: LVP-SW-0005.

    UDI-DI
    • 00811505030122

Recall details

Company began the recall
Company
Fresenius Kabi USA, LLCNorth Andover, Massachusetts
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98106
Recall number
Z-1048-2026
Quantity recalled
30 units

All recalls from Fresenius Kabi USA, LLC

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)